Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT-PCR

被引:32
作者
Caron, E
Rioux, N
Nicolas, O
Lebel-Talbot, H
Hamelin, BA [1 ]
机构
[1] Shire Biochem Inc, Dept Pharmacol & Toxicol, Laval, PQ, Canada
[2] Shire Biochem Inc, Dept Virol, Laval, PQ, Canada
[3] Univ Laval, Fac Pharm, Ste Foy, PQ G1K 7P4, Canada
关键词
CYP; induction; rat liver; RT-PCR;
D O I
10.1002/jbt.20103
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The administration of xenobiotics may significantly alter the expression of cytochromes P450 (CYPs), thereby leading to potentially toxic cellular, physiologic, and pharmacologic responses. Indeed, an important task in the development of new therapeutic entities is to evaluate efficiently and quantitatively their potential effects on the expression level of different CYPs. In this report, reverse transcriptase polymerase chain reaction (RT-PCR) was used to measure basal and induced mRNA of a wide range of rat CYP isoforms. Rats (n = 3 per treatment) were treated with five prototype inducers of CYP isoforms or with vehicle only. RT and PCR efficiencies were determined using appropriate RNA and DNA standards. Messenger RNA was quantified by PicoGreen standard curves and normalized to cyclophilin. Quantitative RT-PCR was used successfully to demonstrate that CYP isoforms were induced at the mRNA level following drug administration. Notably, phenobarbital resulted in significant induction of CYP2B1, CYP2B2, CYP2C6, CYP2C13, CYP2E1, CYP3A1, and CYP3A2.3-Methylcholanthrene induced CYP1A1, CYP1A2, and CYP1B1. CYP2C11 expression was highly variable and suppressed by pyridine, whereas the expression of CYP2E1. was suppressed by dexamethasone. We demonstrated that quantitative RT-PCR can be used to evaluate efficiently the effect of compounds on the expression of a wide range of CYP isoforms. The technique is advantageous over others in that it is very sensitive, efficient and applicable to highly homologous CYP isoforms. (c) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:368 / 378
页数:11
相关论文
共 40 条
  • [31] Evidence for a tissue-specific induction of cutaneous CYP2E1 by dexamethasone
    Sampol, E
    Mirrione, A
    Villard, PH
    Piccerelle, P
    Scoma, H
    Berbis, P
    Barra, Y
    Durand, A
    Lacarelle, B
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) : 557 - 561
  • [32] Schilter B, 2000, J PHARMACOL EXP THER, V294, P916
  • [33] GENDER DIFFERENCES IN DRUG-METABOLISM REGULATED BY GROWTH-HORMONE
    SHAPIRO, BH
    AGRAWAL, AK
    PAMPORI, NA
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1995, 27 (01) : 9 - 20
  • [34] Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR
    Sumida, A
    Fukuen, S
    Yamamoto, I
    Matsuda, H
    Naohara, M
    Azuma, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 267 (03) : 756 - 760
  • [35] Housekeeping genes as internal standards: use and limits
    Thellin, O
    Zorzi, W
    Lakaye, B
    De Borman, B
    Coumans, B
    Hennen, G
    Grisar, T
    Igout, A
    Heinen, E
    [J]. JOURNAL OF BIOTECHNOLOGY, 1999, 75 (2-3) : 291 - 295
  • [36] Interference with growth hormone stimulation of hepatic cytochrome P4502C11 expression in hypophysectomized male rats by 3-methylcholanthrene
    Timsit, YE
    Riddick, DS
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 163 (02) : 105 - 114
  • [37] WAXMAN DJ, 1984, J BIOL CHEM, V259, P5481
  • [38] IN-VITRO METHODS FOR ASSESSING HUMAN HEPATIC DRUG-METABOLISM - THEIR USE IN DRUG DEVELOPMENT
    WRIGHTON, SA
    VANDENBRANDEN, M
    STEVENS, JC
    SHIPLEY, LA
    RING, BJ
    RETTIE, AE
    CASHMAN, JR
    [J]. DRUG METABOLISM REVIEWS, 1993, 25 (04) : 453 - 484
  • [39] Yan Zhengyin, 2001, Current Topics in Medicinal Chemistry, V1, P403, DOI 10.2174/1568026013395001
  • [40] YOSHIHARA S, 1982, J PHARMACOBIO-DYNAM, V5, P994